A bond is a debt security that can be traded freely on the open market and represents part of a loan. Bonds are an ideal diversification tool for investors. There are a number of reasons why investing ...

Cloudberry Clean Energy ASA ("Cloudberry" or the "Company) has entered into an agreement with a European infrastructure investor ("the Investor") to establish one of the largest small-scale hydro ...

Home Equities - Stocks - Shares Company Press Releases 2020 Bulkers Ltd. (2020) Commercial Update and Key Information Relating To The Dividend For June 2025 ...

8 July 2025 - ReFuels N.V., a leading European supplier of renewable biomethane (Bio-CNG) for the decarbonisation of heavy goods vehicles (HGVs), today published Bio-CNG station data for June 2025. * ...

Cloudberry Clean Energy ASA ("Cloudberry" or the "Company"), together with Hafslund Vekst AS, is pleased to announce that the partners have reached a final investment decision (FID) in the joint ...

is owned by HC (60%) and HSC (40%). The condition for completion of the Offer relating to "Minimum Acceptance" as set out in section 1.3 of the Offer Document has, as previously announced, already ...

Press ReleaseVELIZY-VILLACOUBLAY, France — July 7, 2025 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Das ...

(July 9, 2025 - Oslo, Norway) Nel ASA (Nel, OSE:NEL) will publish its second quarter 2025 report on 16 July 2025 at 07:00 CET, and host a pr ...

Home Equities - Stocks - Shares Company Press Releases Ensurge Micropower ASA - Business Update and Contemplated Fully Underwritten Private Placement ...

Fornebu, Norway – 8 July 2025 – Telenor announces the acquisition of GlobalConnect’s consumer business in Norway in a transaction valued at NOK 6.0 billion. The deal marks a significant strategic step ...

Reference is made to stock exchange notice of 1 March 2024, where Endúr ASA (“The Company”) announced its plan to buy up to 1,629,741 own shares for a total maximum NOK 50 million. In week 27 2025, ...

Oslo, Norway, July 9, 2025 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that a ...